Saliva Collection and Diagnostics

Global Saliva Collection and Diagnostics Market to Reach US$983.6 Million by 2030

The global market for Saliva Collection and Diagnostics estimated at US$794.5 Million in the year 2024, is expected to reach US$983.6 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Parotid Gland Collection, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$555.4 Million by the end of the analysis period. Growth in the Submandibular / Sublingual Gland Collection segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$216.4 Million While China is Forecast to Grow at 6.7% CAGR

The Saliva Collection and Diagnostics market in the U.S. is estimated at US$216.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$196.5 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Saliva Collection and Diagnostics Market – Key Trends & Drivers Summarized

Why Is Saliva-Based Diagnostics Gaining Popularity In The Healthcare Industry?

Saliva collection and diagnostics are transforming non-invasive medical testing, offering a convenient alternative to traditional blood tests. Saliva-based diagnostics are increasingly being used for disease detection, genetic testing, hormone analysis, and drug monitoring. The growing demand for home-based and point-of-care testing, particularly following the COVID-19 pandemic, has accelerated the adoption of saliva testing kits. These tests eliminate the need for needles, reducing patient discomfort and making diagnostics more accessible for children, elderly individuals, and those with needle phobia. With advancements in biotechnology, saliva-based diagnostics are now being used for early disease detection, including cancer, infectious diseases, and neurological disorders. As the demand for rapid and non-invasive diagnostics increases, the saliva collection and diagnostics market is experiencing significant growth.

What Technological Innovations Are Enhancing Saliva-Based Diagnostics?

Breakthroughs in molecular biology and biosensor technology are improving the accuracy and efficiency of saliva diagnostics. PCR-based (polymerase chain reaction) saliva tests are enabling highly sensitive detection of viral and bacterial infections. AI-powered data analysis and lab-on-a-chip technology are streamlining saliva-based genetic testing, allowing for faster and more precise results. Wearable biosensors that continuously monitor biomarkers in saliva are also emerging, providing real-time health tracking without invasive procedures. Additionally, improvements in saliva collection devices, such as stabilization buffers that preserve DNA and RNA integrity, are expanding the range of conditions that can be diagnosed using saliva samples. These innovations are making saliva-based testing a powerful tool for preventive and personalized medicine.

Which Healthcare Sectors Are Driving The Demand For Saliva Collection And Diagnostics?

The growing need for non-invasive diagnostics is driving adoption across multiple healthcare sectors, including infectious disease testing, genetic screening, endocrinology, and forensic science. The pharmaceutical industry is using saliva testing for drug development and clinical trials, while sports medicine professionals rely on saliva-based hormone monitoring to assess athlete performance and recovery. The rise of telemedicine and home healthcare services is further fueling demand for at-home saliva collection kits, enabling patients to submit samples without visiting a clinic. Additionally, the forensic and law enforcement sectors are increasingly using saliva-based DNA testing for criminal investigations and identity verification. With applications expanding across various fields, saliva diagnostics is becoming a mainstream healthcare solution.

What Factors Are Fueling The Growth Of The Saliva Collection And Diagnostics Market?

The growth in the saliva collection and diagnostics market is driven by rising demand for non-invasive testing, advancements in molecular diagnostics, and the expansion of telehealth services. The COVID-19 pandemic accelerated investment in saliva-based diagnostics for rapid viral detection, highlighting their potential for broader disease screening. The increasing prevalence of chronic diseases, including cancer and diabetes, is also driving research into saliva-based biomarker detection. The push for personalized medicine is leading to greater adoption of genetic and epigenetic testing using saliva samples. Additionally, government initiatives promoting early disease detection and affordable diagnostics are supporting market expansion. As technology continues to improve, saliva-based testing is expected to play a pivotal role in the future of healthcare.

SCOPE OF STUDY:

The report analyzes the Saliva Collection and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Collection Site (Parotid Gland Collection, Submandibular / Sublingual Gland Collection, Others); Application (Disease Diagnostics, Forensic Applications, Research); End-Use (Dentistry, Diagnostic Laboratories, Pharma & Biotech Companies, Research Institutes)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott
• Abionic SA
• Arcis Biotechnology Ltd.
• AutoGen, Inc.
• DNA Genotek (an OraSure company)
• Eli Health
• Hardy Diagnostics
• Neogen Corporation
• Oasis Diagnostics
• OraSure Technologies
• Phadebas
• Porex
• Salignostics
• Salimetrics, LLC
• Sarstedt AG & Co. KG
• Spectrum Solutions
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• ZRT Laboratory
• Zymo Research

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.